Skip to content

Barriers to HCV treatment access from the drug user's point of view: stigma, complex lives and damaged veins

Social and network factors may explain higher HIV infection rates for black men who have sex with men in the US

Multi-drug resistant Shigella detected in the UK and USA, mostly in gay men

Atripla or efavirenz plus Truvada failed one in 16 people in first year

Efavirenz in pregnancy is at least as safe as other antiretrovirals

Half of Malaysian doctors admit to some discrimination against patients with HIV

HIV and schistosomiasis programmes should be combined to reduce the spread of HIV

Co-infection with HIV and HCV does not increase the risk of end-stage liver disease or liver cancer

Meta-analysis finds high but variable STI rates in PrEP studies – is PrEP the cause or a potential solution?